Inez Schoenmakers
Sun 20 10:15
SS1.1
Special Symposium: Bone & Vitamin D
Free and bound vitamin D and health outcomes.
Martin Fassnacht
Sun 20 15:15
GL1.1
European Society of Endocrinology Clinical Practice Guidelines on the Management of Adrenocortical Carcinoma in Adults, in collaboration with the European Network for the Study of Adrenal Tumors
Introduction to ENSAT Guidelines
Sun 20 16:00
GL1.5
European Society of Endocrinology Clinical Practice Guidelines on the Management of Adrenocortical Carcinoma in Adults, in collaboration with the European Network for the Study of Adrenal Tumors
Therapy of advanced ACC
Massimo Terzolo
Sun 20 15:45
GL1.4
European Society of Endocrinology Clinical Practice Guidelines on the Management of Adrenocortical Carcinoma in Adults, in collaboration with the European Network for the Study of Adrenal Tumors
Adjuvant therapy
Martin Fassnacht
Sun 20 15:15
GL1.1
European Society of Endocrinology Clinical Practice Guidelines on the Management of Adrenocortical Carcinoma in Adults, in collaboration with the European Network for the Study of Adrenal Tumors
Introduction to ENSAT Guidelines
Sun 20 16:00
GL1.5
European Society of Endocrinology Clinical Practice Guidelines on the Management of Adrenocortical Carcinoma in Adults, in collaboration with the European Network for the Study of Adrenal Tumors
Therapy of advanced ACC
Harm Haak
Sun 20 16:15
GL1.6
European Society of Endocrinology Clinical Practice Guidelines on the Management of Adrenocortical Carcinoma in Adults, in collaboration with the European Network for the Study of Adrenal Tumors
Special considerations on mitotane
Giovanna Mantovani
Mon 21 15:15
S19.1
Symposium 19: New Aspects of Pituitary Regulation
Cytoskeleton and pharmacologic resistance in pituitary tumours
John Todd
Tue 22 09:45
S23.1
Symposium 23: Pre-diabetes
What have we learnt so far about the immunogenetics of type 1 diabetes?
Clemens Schmitt
Tue 22 10:15
S25.2
Symposium 25: Late breaking
Senescence-associated reprogramming promotes cancer stemness
Alberto Pereira
Tue 22 09:45
Endo-ERN: concrete examples of added value for patient care
Introduction, structure, and virtual consultation using the EU-ERN CPMS
Mrs Manuela Brösamle
Tue 22 10:15
Endo-ERN: concrete examples of added value for patient care
Patient and family perspectives
Dr Scott Akker
London, UK
Tue 22 10:15
S21.2
Symposium 21: The Dance of Adrenal and Gonads
Management of phaeochromocytoma during pregnancy
London, UK
Frederique Albarel
Mon 21 16:15
S19.3
Symposium 19: New Aspects of Pituitary Regulation
How cancer treatment effects your pituitary
Krystallenia Alexandraki
Tue 22 15:45
S26.3
Symposium 26: Cortisol: Too much of a Good Thing
Differentiating Cushing from Pseudo-Cushing
Jayakumar Ambigapathy
Sun 20 12:48
OC2.5
Oral Communication: Look who is controlling your gonads!
Effect of thyroxine replacement on leydig cell and sertoli cell function in men with hypothyroidism
Karin Amrein
Sun 20 10:45
SS1.2
Special Symposium: Bone & Vitamin D
Vitamin D and Critical Care
Sof Andrikopoulos
Melbourne, Australia
Mon 21
PW1.4
Publishing Workshop
Publishing ethics
Melbourne, Australia
Anna Angelousi
Mon 21 11:20
S15.5
Symposium 15: European Young Endocrine Scientists (EYES) New aspects in the study of neuroendocrine diseases
Alterations in Clock genes expression in human benign adrenal tumors
Natasha Appelman
Mon 21 10:45
S12.2
Symposium 12: Why do fractures occur in endocrine disorders and how should they be handled?
Bone quality evaluation in Pituitary diseases
Peter Arner
Tue 22 10:45
S22.3
Symposium 22: The fatty bone
Cross-talk between bone marrow and periperal adipose tissue in man
Guillaume Assié
Sun 20 15:30
GL1.3
European Society of Endocrinology Clinical Practice Guidelines on the Management of Adrenocortical Carcinoma in Adults, in collaboration with the European Network for the Study of Adrenal Tumors
Pathology & Prognostic factors
Guillaume Assié
Mon 21 12:00
OC7.1
Oral Communication: Genomic and clinical aspects of endocrine tumours
Molecular classification of benign adrenocortical tumors: an integrated genomic study
Tais Assmann
Mon 21 12:12
OC8.2
Oral Communication: MicroRNAs as biomarkers in endocrine diseases
MicroRNA expression profiling and functional annotation analysis of their targets in patients with diabetic kidney disease.
Julie Bakker
Belgium
Tue 22 15:45
S30.3
Symposium 30: Disorders of Sexual Development (DSD)
Gender Dysphoria and Brain Function
Belgium
Irina Bancos
Mon 21 12:12
OC7.2
Oral Communication: Genomic and clinical aspects of endocrine tumours
Urine steroid metabolomics as a diagnostic tool for detection of adrenocortical malignancy – a prospective test validation study
Zhanna Belaya
Tue 22 15:45
S27.3
Symposium 27: Emerging treatments in osteoporosis
Sequential and combination therapy for osteoporosis
Carlos Bernal-Mizrachi
Sun 20 11:15
SS1.3
Special Symposium: Bone & Vitamin D
Vitamin D, macrophages and atherosclerosis
Stella Bernardi
Sun 20 12:24
OC4.3
Oral Communication: Novel insights into prediabetes and type 2 diabetes
Effects of TRAIL delivery on an experimental model of type 2 diabetes and diabetic nephropathy
Filippo Biscarini
Mon 21 12:36
OC8.4
Oral Communication: MicroRNAs as biomarkers in endocrine diseases
Detecting blood micro-RNAs and proteins associated with Graves’ disease and orbitopathy
Ulrich Boehm
Mon 21 10:15
S14.1
Symposium 14: Neuroendocrine basis of reproductive disorders
Developmental wiring of GnRH neurons
Dr Kristien Boelaert
Birmingham, UK
Tue 22
D5.1
Debate 5: Pregnant women should be screened for thyroid hormones and antibodies
FOR - Pregnant women should be screened for thyroid hormones and antibodies
Birmingham, UK
Jens Bollerslev
Mon 21 11:15
S12.3
Symposium 12: Why do fractures occur in endocrine disorders and how should they be handled?
Effect of parathyroid dysfunction on incidence of bone fractures
Riccardo Bonadonna
Tue 22 10:45
S23.3
Symposium 23: Pre-diabetes
Treatment of pre type 2 diabetes
Francesc Borras
Tue 22 09:45
S25.1
Symposium 25: Late breaking
Microvesicles and exosomes: new players in metabolic diseases
Philippe Bouchard
Sat 19 19:25
PL1
Plenary 1: Contraception: Past and future
Contraception: Past and future
Alexandre Buffet
Mon 21 12:36
OC7.4
Oral Communication: Genomic and clinical aspects of endocrine tumours
Germline mutations in the mitochondrial 2-oxoglutarate/malate carrier (SLC25A11) gene confer predisposition to metastatic paragangliomas.
E Buitenwerf
Mon 21 12:48
OC7.5
Oral Communication: Genomic and clinical aspects of endocrine tumours
Randomized trial comparing phenoxybenzamine and doxazosine for preoperative treatment of patients with a pheochromocytoma (PRESCRIPT)
Biagio Cangiano
Tue 22 11:54
OC12.3
Oral Communication: Novel aspects of puberty development and Cushing's disease
Evaluation of genetic predisposition in severe and mild phenotypes of isolated hypogonadotropic hypogonadism
Albert Cano
Tue 22 12:18
OC14.5
Oral Communication: What is new in gestational and type 1 diabetes?
Type 1 diabetes mellitus: defining the best cut-off points of arterial stiffness for predicting cardiovascular risk according to the Steno Type 1 Risk Engine
Philippe Caron
Sun 20 12:00
OC1.1
Oral Communication: Benign thyroid diseases
Familial gestational hyperthyroidism caused by Val597Ile mutant of TSH receptor gene with human chorionic gonadotropin hypersensitivity
Isadora Cavalcante
Mon 21 12:48
OC5.5
Oral Communication: Diving deep into adrenal cortex diseases
Cullin 3 is a partner of Armadillo Repeat Containing 5 (ARMC5), the product of the gene responsible for Primary Bilateral Macronodular Adrenal Hyperplasia
William Cawthorn
Tue 22 10:15
S22.2
Symposium 22: The fatty bone
Bone marrow adipose tissue: starving for attention?
Giovanni Ceccarini
Mon 21 15:45
S20.2
Symposium 20: All you need to know about lipodystrophy
Acquired forms of lipodystrophy
Philippe Chanson
Mon 21 17:15
CET1
Clinical Endocrinology Trust Lecture - Growth Hormone: not too much...not too less!
Growth Hormone: not too much...not to less!
Kristina Chen
Sun 20 12:36
OC3.4
Oral Communication: New insights in bone disorders
Renal function change in chronic hypoparathyroidism patients treated with recombinant human parathyroid hormone (1-84) (rhPTH[1-84]) and in a historical control cohort treated with standard therapy
Irina Chifu
Mon 21 12:36
OC5.4
Oral Communication: Diving deep into adrenal cortex diseases
Assessment of Tissue Sodium Content by 23Na-MRI in Patients with Adrenal Insufficiency – a Pilot Study
Luca Chiovato
Sun 20 10:45
S1.2
Symposium 1: Predicting events in autoimmune thyroid disease
IgG4 related thyroid autoimmune disease
Mon 21
D3.1
Debate 3: Subclinical hypothyroidism is a disease
FOR - Subclinical hypothyroidism is a disease
Ioana Chisalita
Sun 20 12:12
OC4.2
Oral Communication: Novel insights into prediabetes and type 2 diabetes
Toe brachial index predicts major adverse cardiovascular events in patients with type 2 diabetes
Sun Cho
Korea, Republic of
Mon 21 12:12
OC9.2
Oral Communication: Thyroid from basics to clinics
Anti-tumoral effects of metformin on metastatic bone lesions of thyroid cancer
Korea, Republic of
Thomas Clemens
Tue 22 14:45
S27.1
Symposium 27: Emerging treatments in osteoporosis
Molecular basis of bone anabolism
Sabrina Corbetta
Mon 21 12:24
OC7.3
Oral Communication: Genomic and clinical aspects of endocrine tumours
IncRNAs profiling reveals epigenetic heterogeneity among human parathyroid tumor
Giovanni Corona
Sun 20 16:15
S9.3
Symposium 9: European academy of andrology/ESE Session: Male gonadal function versus general health and vice versa
Does "healthy obesity" exist in andrology? 
Professor Sabine Costagliola
Brussels, Belgium
Tue 22
NSA6
New Scientific Approach 6 - Functional thyroid in the dish
Functional thyroid in the dish
Brussels, Belgium
Mr Sherwin Criseno
Birmingham , United Kingdom
Sun 20 11:15
N1.3
Nurses MDT symposium: Immunotherapy: The Good, The Bad and Witty
The Witty - The Role of Endocrine Nurse in Managing Patients with Immunotherapy-induced Endocrinopathy
Birmingham , United Kingdom
Guido Dalmazi
Mon 21 12:12
OC5.2
Oral Communication: Diving deep into adrenal cortex diseases
Steroid profiling by liquid chromatography tandem mass spectrometry in a large cohort of patients with adrenal incidentalomas
Jaap Deinum
Sun 20
D1.2
Debate 1 - Adrenal venous sampling vs. imaging for primary aldosteronism: beware of the caveats!
Against - Adrenal venous sampling vs. imaging for primary aldosteronism: beware of the caveats!
Olaf Dekkers
Sun 20 15:20
GL1.2
European Society of Endocrinology Clinical Practice Guidelines on the Management of Adrenocortical Carcinoma in Adults, in collaboration with the European Network for the Study of Adrenal Tumors
Methods
Didier Dewailly
Mon 21 12:15
D4.1
Debate 4: AMH as the Primary Marker for Fertility
FOR - AMH as the Primary Marker for Fertility
Maeve Durkan
Sun 20
UEM1.1
UEMS session - Session of the European Union of Medical Specialists Section of Endocrinology
News from Brussels
Tina Dusek
Mon 21
MTE8
Meet The Expert 8 - Hormone replacement for the travelling patient
Hormone replacement for the travelling patient
Grigoris Effraimidis
Sun 20 10:15
S1.1
Symposium 1: Predicting events in autoimmune thyroid disease
The THEA score in familial thyroid dysfunction
Rossella Elisei
Mon 21 16:15
S16.3
Symposium 16: Changing practice in the management of thyroid neoplasms
New classification and guidelines in differentiated thryroid cancers
Murat Erdogan
Mon 21 15:45
S16.2
Symposium 16: Changing practice in the management of thyroid neoplasms
Composite approach in the evaluation and management of thyroid nodule
Eduardo Eyras
Sun 20 14:00
NSA2
New Scientific Approach 2 - The spliceosome as a target treatment of endocrine tumours
The spliceosome as a target treatment of endocrine tumours
Judith Favier
Mon 21 10:40
S15.3
Symposium 15: European Young Endocrine Scientists (EYES) New aspects in the study of neuroendocrine diseases
Epigenetic and metabolic reprogramming of SDH deficient pheochromocytomas and paragangliomas
Ulla Feldt-Rasmussen
Mon 21
D3.2
Debate 3: Subclinical hypothyroidism is a disease
AGAINST - Subclinical hypothyroidism is a disease
Tiziana Feola
Tue 22 12:06
OC13.4
Oral Communication: The curious case of growth hormone
Effects of Pegvisomant on Glucose Metabolism in Acromegaly: A Meta-analysis of Prospective Interventional Studies
Anna Ferrulli
Mon 21 12:12
OC6.2
Oral Communication: Genetic and environmental determinants of obesity and insulin resistance
DEEP TRANSCRANIAL MAGNETIC STIMULATION ACUTELY MODULATES NEURO-ENDOCRINE PATHWAYS UNDERLYING OBESITY
Jose. Florez
Sun 20 15:15
S6.1
Symposium 6: Precision Medicine for diabetes
Pharmacogenetics in type 2 diabetes: precision medicine or discovery tool?
Ines Foessl
Mon 21 12:48
OC8.5
Oral Communication: MicroRNAs as biomarkers in endocrine diseases
MicroRNA profiles in diabetic octogenarians with and without historical and prospective hip fractures
Renata Frazao
Tue 22 11:30
OC12.1
Oral Communication: Novel aspects of puberty development and Cushing's disease
Growth hormone signaling in leptin receptor expressing cells, but not in Kiss1 expressing neurons, regulates the timing of puberty
Jérôme Frenette
Sun 20 12:12
OC3.2
Oral Communication: New insights in bone disorders
Can a bone protein protect against muscular dystrophy?
Isadora Furigo
Tue 22 12:18
OC13.5
Oral Communication: The curious case of growth hormone
Growth hormone acts in AGRP neurons to control energy expenditure during food restriction and promotes counter-regulatory responses to hypoglycemia via the ventromedial hypothalamus
Manuel Gahete
Sun 20 08:00
MTBS1
Meet The Expert - Basic Scientist 1: Mouse models in endocrine tumors
Mouse models in endocrine tumors